[The treatment of diabetes mellitus: myths and evidence]

Burkhard Göke1

  • 1Universitätsklinikum Hamburg-Eppendorf, Haus O 35, Martinistraße 52, 20246, Hamburg, Deutschland. goeke@uke.de.

Insights

This review examines persistent myths about diabetes mellitus origins and treatment, highlighting advancements in understanding and therapy. It discusses evolving treatment strategies beyond glucose control, incorporating molecular medicine and personalized approaches.

Area of Science:

  • Endocrinology and Metabolic Diseases
  • History of Medicine

Background:

  • Metabolic disorders with diabetes mellitus-like symptoms have been recognized for over 3500 years.
  • Historical understanding of diabetes mellitus etiology and treatment was limited, fostering persistent myths.
  • Significant advances in pathophysiology understanding occurred approximately 200 years ago, improving treatment efficacy.

Purpose of the Study:

  • To review current myths surrounding the genesis and treatment of diabetes mellitus.
  • To discuss the growing evidence for improved diabetes therapies.
  • To explore the impact of molecular medicine and personalized approaches on future diabetes treatment paradigms.

Main Methods:

  • Literature review of historical and current understanding of diabetes mellitus.
  • Analysis of evolving therapeutic concepts, moving beyond glucocentric approaches.
  • Discussion of the role of molecular medicine, new drugs, personalized medicine, and technical innovations.

Main Results:

  • Despite advances, outdated myths continue to influence diabetes mellitus treatment.
  • Current research increasingly focuses on cardiovascular endpoints and realistic therapeutic goals.
  • Polyvalent treatment concepts are emerging, extending beyond traditional glucose-centered strategies.

Conclusions:

  • New therapeutic paradigms for diabetes mellitus are emerging, driven by molecular medicine and personalized approaches.
  • Traditional and novel myths may persist and influence the development of future diabetes treatments.
  • Awareness of these myths is crucial for developing effective and evidence-based diabetes care strategies.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
785
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K